What is the recommended pediatric dosing schedule for baclofen, including initial dose, titration, and maximum dose?

Pediatric Baclofen Dosing

For oral baclofen in children, start with 0.2-0.5 mg/kg/day divided into 3 doses, then titrate gradually every 3 days by 0.2-0.5 mg/kg/day increments until optimal effect is achieved, with a typical maintenance dose of 1-2 mg/kg/day and a maximum of 2.5 mg/kg/day or 80 mg/day (whichever is lower).

Initial Dosing Strategy

The FDA-approved adult dosing schedule provides the framework, but pediatric practice requires weight-based adaptation 1. Recent real-world data from 108 infants demonstrates that clinicians typically initiate at 0.2 mg/kg per dose (0.5 mg/kg/day total daily dose) given three times daily, which is considerably more conservative than older recommendations 2.

For practical implementation:

• Starting dose: 0.2-0.5 mg/kg/day divided TID
• Frequency: Three times daily is standard (56.5% of patients in recent practice) 2
• Age considerations: Infants under 12 months require the lower end of dosing ranges

Titration Protocol

Increase the dose every 3 days based on clinical response 1:

• Week 1: 0.2-0.5 mg/kg/day divided TID
• Week 2: Increase by 0.2-0.5 mg/kg/day if inadequate response
• Subsequent weeks: Continue gradual increases every 3 days

The median longest-tolerated regimen in infants was 0.4 mg/kg per dose (1.3 mg/kg/day total), demonstrating that most patients stabilize well below maximum doses 2.

Maintenance and Maximum Dosing

Target maintenance dose: 1-2 mg/kg/day divided TID-QID

Maximum dose: The lower of:

• 2.5 mg/kg/day, OR
• 80 mg/day total 1, 3

Real-world data shows mean dosages of 40 mg/day are typical, though some children with cerebral palsy or traumatic brain injury required up to 240 mg/day 3. However, such high doses are exceptional and require careful monitoring.

Critical Considerations by Etiology

Cerebral-origin spasticity (cerebral palsy, traumatic brain injury):

• Requires higher doses than spinal-origin spasticity
• Mean dose: 40 mg/day, but highly variable 3
• Duration post-injury predicts dose requirements 3

Spinal-origin spasticity:

• Generally requires lower doses
• Faster titration may be tolerated (10-30% increases every 24 hours in acute settings) 4

Safety Profile

Baclofen was well-tolerated in pediatric studies with only 3.7% discontinuation due to adverse effects (primarily sedation and emesis) 2. Monitor for:

• Sedation (most common)
• Respiratory depression (especially with concomitant sedatives)
• Withdrawal symptoms if abruptly discontinued

Weaning Oral Antispasmodics

When initiating baclofen, wean other oral antispasmodics one drug at a time, starting with oral baclofen if the patient was already on it, after ITB therapy begins 4. This principle applies to oral-to-oral transitions as well.

Common Pitfalls

1. Starting too high: Recent practice favors lower initial doses (0.2 mg/kg) than historical recommendations, improving tolerability 2
2. Inadequate titration time: Allow 3 days between dose adjustments to assess response 1
3. Abrupt discontinuation: Always taper gradually to avoid withdrawal seizures and hallucinations 1
4. Ignoring age-specific factors: Infants require more conservative dosing than older children 2

The high interindividual variability (52% average dose change during follow-up) underscores that while these guidelines provide structure, close monitoring and adjustment based on individual response remains essential 2, 5.